Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
MEI Pharma Inc (MEIP)  
$3.33 0.04 (1.12%) as of 4:30 Tue 4/23


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 66,620,000
Market Cap: 222.00(M)
Last Volume: 14,666 Avg Vol: 14,625
52 Week Range: $3.2 - $7.84
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drug Manufacturers - Other

Member Indexes:
    NASDAQ COMPOSITE     NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   MEI Pharma is a late-stage pharmaceutical company focused on the development and commercialization of cancer therapies to improve outcomes for patients. Co.'s portfolio of drug candidates includes three clinical-stage assets, including: Zandelisib, an oral phosphatidylinositol 3-kinase delta inhibitor; Voruciclib, an oral cyclin-dependent kinase 9 inhibitor; and ME-344, a mitochondrial inhibitor targeting the oxidative phosphorylation complex.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 336,100 417,600
Total Buy Value $0 $0 $2,112,595 $2,130,933
Total People Bought 0 0 2 3
Total Buy Transactions 0 0 6 7
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2024-01-25 2023-10-24 2023-04-25 2022-04-25

   
Records found: 54
  Page 1 of 3  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Wood Steven D   –       •      –    2023-10-31 3 IO $0.00 $0 I/I 0 67,733 -39%     
   Wood Steven D   –       •      –    2023-10-31 3 IO $0.00 $0 D/D 0 1,259 -39%     
   Ma-Weaver Jacob 10% Owner   –       –       •   2023-10-20 4 OE $7.00 $844,200 I/I 120,600 611,440     -
   Winson Bruce Ross 10% Owner   –       –       •   2023-10-20 4 OE $7.00 $1,253,000 I/I 179,000 1,093,188     -
   Ma-Weaver Jacob 10% Owner   –       –       •   2023-10-11 4 OE $7.00 $210,000 I/I 30,000 490,840     -
   Winson Bruce Ross 10% Owner   –       –       •   2023-10-11 4 OE $7.00 $350,000 I/I 50,000 914,188     -
   Ma-Weaver Jacob 10% Owner   –       –       •   2023-09-22 4 B $6.85 $219,554 I/I 32,040 460,840 1.5 -40%     
   Winson Bruce Ross 10% Owner   –       –       •   2023-09-22 4 B $6.85 $329,331 I/I 48,060 864,188 1.5 -40%     
   Ma-Weaver Jacob 10% Owner   –       –       •   2023-09-21 4 B $6.46 $144,740 I/I 22,400 428,800 1.5 -32%     
   Winson Bruce Ross 10% Owner   –       –       •   2023-09-21 4 B $6.46 $217,110 I/I 33,600 816,128 1.5 -32%     
   Ma-Weaver Jacob 10% Owner   –       –       •   2023-09-20 4 B $6.01 $480,744 I/I 80,000 406,400 1.5 -26%     
   Winson Bruce Ross 10% Owner   –       –       •   2023-09-20 4 B $6.01 $721,116 I/I 120,000 782,528 1.5 -26%     
   Ma-Weaver Jacob 10% Owner   –       –       •   2023-05-19 3 IO $0.00 $0 D/D 0 326,400 -5%     
   Winson Bruce Ross 10% Owner   –       –       •   2023-05-19 3 IO $0.00 $0 I/I 0 662,528 -5%     
   Baltic Charles V. Iii Director   –       •      –    2023-02-28 4 B $0.23 $18,338 D/D 81,500 105,750 2.39     -
   Ghalie Richard G Chief Medical Officer   •       –      –    2022-07-05 4 D $0.54 $4,426 D/D (8,196) 28,927     -
   Gold Daniel P Phd Chief Executive Officer   •       •      –    2021-07-02 4 D $2.94 $121,481 D/D (41,320) 417,312     -
   Urso David M Chief Operating Officer & GC   •       –      –    2021-07-02 4 D $2.94 $72,986 D/D (24,825) 49,281     -
   Gold Daniel P Phd Chief Executive Officer   •       •      –    2021-05-25 4 OE $2.52 $12,600 D/D 5,000 458,632     -
   Driscoll Frederick W Director   –       •      –    2021-02-23 4 S $4.03 $100,625 D/D (25,000) 37,500     -
   Gold Daniel P Phd Chief Executive Officer   •       •      –    2020-07-23 4 OE $1.57 $18,840 D/D 12,000 453,632     -
   Urso David M Chief Operating Officer & GC   •       –      –    2020-07-02 4 A $0.00 $0 D/D 50,000 74,106     -
   Gold Daniel P Phd Chief Executive Officer   •       •      –    2020-07-02 4 A $0.00 $0 D/D 80,000 441,632     -
   Drazba Brian G. Chief Financial Officer   •       –      –    2019-12-19 4 B $1.60 $20,000 D/D 12,500 37,500 2.74     -
   Driscoll Frederick W Director   –       •      –    2019-12-19 4 B $1.60 $100,000 D/D 62,500 62,500 2.39     -
  54 Records found
  1  2  3   
  Page 1 of 3
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us